About this article Cite this article Akano, O.P., Olatinwo, G., Hamed, M.A
Dec 22, 2025 / Jan 2026 Wegovy 25mg Oral Pill FDA Approved The first and only FDA-approved GLP-1 pill specifically for weight loss
Criteria for treatment and management Optimum maintenance dose is 1000 g at intervals of 12 weeks Follow-up annual blood count is required to avoid relapse You see the obsession with blood values and yet no instruction to listen to patients, some of whom relapse only a matter of days post injection
BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency
Hypothyroidism, polycystic ovary syndrome (PCOS), Cushing's syndrome, and certain medications can promote weight gain or make weight loss more difficult
patients should stop treatment and seek medical advice immediately if they develop jaundice, dark urine, itching, or right upper quadrant pain